Zurich Cantonal Bank
CRMD icon

Zurich Cantonal Bank’s CorMedix CRMD Stock Holding History

Zurich Cantonal Bank’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-14,553
Closed -$169K – 2805
2025
Q4 		$169K Buy
+14,553
New +$161K ﹤0.01% 2277

Other funds holding CRMD

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Zurich Cantonal Bank's CRMD Position: Q1 2026 in Review

Zurich Cantonal Bank opened a new position in CorMedix (CRMD) in Q1 2026: 13,588 shares worth $92.3K. The stake represents ﹤0.01% of the portfolio and ranks #2391 among its holdings. This is a return to the name: Zurich Cantonal Bank previously reported a position in CRMD as recently as Q3 2025.

Zurich Cantonal Bank first reported a position in CRMD in Q1 2025 and has held it in 4 quarters since. The position peaked at $185K in Q2 2025. 187 funds tracked by Wall St. Rank hold CRMD as of Q1 2026.

  • Zurich Cantonal Bank held 13,588 shares of CorMedix worth $92.3K as of Q1 2026.
  • CorMedix was a new Zurich Cantonal Bank position in Q1 2026.
  • CorMedix made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q1 2026, its #2391 holding.
  • Zurich Cantonal Bank first reported a position in CorMedix in Q1 2025 and has held it in 4 quarters since.
  • Zurich Cantonal Bank's CorMedix position peaked at $185K in Q2 2025.
  • 187 funds tracked by Wall St. Rank held CorMedix as of Q1 2026.

Based on Zurich Cantonal Bank's 13F filing for Q1 2026, filed 15 May 2026.